MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants DehydraTECH(TM) License to Ireland-Based AnodGen Bioceuticals
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the awarding of a five-year, non-exclusive DehydraTECH(TM) license from its wholly-owned subsidiary, Lexaria Pharmaceutical Corp., to AnodGen Bioceuticals of Ireland. According…
-
MissionIRNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Upcoming Event to Highlight Prominent Names and Companies in Decentralized Web Space
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that the Sequire Decentralized Web Conference will take place on June…
-
Flora Growth Corp. (NASDAQ: FLGC) Adding to Cannabis Product Line, Research
Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom Flora’s partnership with former NFL athlete…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Acquisition of Entheon Biomedical’s DMT Clinical Study
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has entered an agreement to acquire the largest phase 1 DMT study conducted to date. The acquisition, conducted through Cybin IRL Limited,…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Earns “In-Process” Rating from US Government FedRAMP Program
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, announced that as part of its efforts to pursue Authority to Authorize (“ATO”) in the Federal Risk and Authorization…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has successfully filed a pre-Investigational New Drug (“IND”) meeting request letter with the U.S. Food and Drug Administration (“FDA”).…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announced Addition to Russell 2000(R), 3000(R) Indexes
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, will be joining the Russell 2000 and 3000® Indexes effective later this month, on June 27, 2022, after the market opens. The company was named…
-
MissionIRNewsBreaks – Tingo Inc. (TMNA) Reports on Annual Shareholder Meeting Results
Tingo (OTC: TMNA), a leading agri-fintech business in Africa, held its Annual Meeting of Stockholders last week. The meeting, which convened on June 2, 2022, had three agenda items, including the election of director nominees. The…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Releases Q4, FY 2021 Financial Report; Announces Partnership with Onassis Holdings (ONSS)
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, is reporting record financial numbers for fiscal year 2021 and Q4 2021. Highlights…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Adelia Has Reached Milestone Achievements
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, announced that Adelia Therapeutics Inc., its wholly owned subsidiary, has achieved significant milestones, which the company identified as Y2, Q2 (i), (vi),…
-
Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar
Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Details for 2022 LD Micro Invitational
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced details for the 2022 LD Micro Invitational. SRAX will host the…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in Japan to Premier Wellness Science Co. Ltd, a wholly owned subsidiary of Premier Anti-Aging Co.…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Spotlighted in “Frontiers in Psychology” Article
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), and its proprietary EMBARK program is the focus of a recent article in the “Frontiers in Psychology” journal. The peer-reviewed article…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO to Appear on Benzinga’s ‘All Access’ Series
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its CEO and chair David Michery are spotlighted during an interview on Benzinga’s All Access Series. The interview is slated for today, June 3,…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better
Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodies Lexaria’s patented…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in the European and United Kingdom markets. The company awarded the nonexclusive licenses to Valcon…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Host Webinar Delving into Psychedelics Landscape, Current and Emerging Therapeutics
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will host a virtual Key Opinion Leader webinar from 11:00 a.m. to 12:00 p.m. ET on…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings
InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced its entry into securities purchase agreements with a single health care-focused institutional investor for…
Search Articles
Latest Articles
- Wearable Devices Ltd. (NASDAQ: WLDS): How Neural Interface Patents Are Securing the Future of Touchless Control
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) CEO to Present at H.C. Wainwright Global Investment Conference
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports Strong Q2/25 Results, Targets Profitability in Early 2026
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Advances Sustainable Development in Alaska’s Ambler Mining District
- SuperCom Ltd. (NASDAQ: SPCB) Secures New U.S. Contracts, Expands Presence into 11th State in Under a Year